Nicholls SJ - Search Results

1

Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.

Nicholls SJ, Lincoff AM, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, Koenig W, McGuire DK, Mozaffarian D, Pedersen TR, Ridker PM, Ray K, Karlson BW, Lundström T, Wolski K, Nissen SE. Nicholls SJ, et al. Clin Cardiol. 2018 Oct;41(10):1281-1288. doi: 10.1002/clc.23055. Epub 2018 Sep 28. Clin Cardiol. 2018. PMID: 30125052 Free PMC article. Review.

2

Antiinflammatory properties of HDL.

Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Barter PJ, et al. Circ Res. 2004 Oct 15;95(8):764-72. doi: 10.1161/01.RES.0000146094.59640.13. Circ Res. 2004. PMID: 15486323 Review.

3

Strategies to promote HDL-C: an emerging therapeutic target.

Nicholls SJ, Nissen SE. Nicholls SJ, et al. Eur Heart J. 2005 May;26(9):853-5. doi: 10.1093/eurheartj/ehi218. Epub 2005 Mar 11. Eur Heart J. 2005. PMID: 15764616 No abstract available.

4

Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits.

Nicholls SJ, Dusting GJ, Cutri B, Bao S, Drummond GR, Rye KA, Barter PJ. Nicholls SJ, et al. Circulation. 2005 Mar 29;111(12):1543-50. doi: 10.1161/01.CIR.0000159351.95399.50. Epub 2005 Mar 21. Circulation. 2005. PMID: 15781735

5

High-density lipoproteins as therapeutic targets.

Nicholls SJ, Rye KA, Barter PJ. Nicholls SJ, et al. Curr Opin Lipidol. 2005 Jun;16(3):345-9. doi: 10.1097/01.mol.0000169356.58513.25. Curr Opin Lipidol. 2005. PMID: 15891397 Review.

6

Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits.

Nicholls SJ, Cutri B, Worthley SG, Kee P, Rye KA, Bao S, Barter PJ. Nicholls SJ, et al. Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2416-21. doi: 10.1161/01.ATV.0000184760.95957.d6. Epub 2005 Sep 1. Arterioscler Thromb Vasc Biol. 2005. PMID: 16141405

7

Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study).

Nicholls SJ, Tuzcu EM, Schoenhagen P, Sipahi I, Crowe T, Kapadia S, Nissen SE. Nicholls SJ, et al. Am J Cardiol. 2005 Dec 15;96(12):1636-9. doi: 10.1016/j.amjcard.2005.07.085. Epub 2005 Oct 28. Am J Cardiol. 2005. PMID: 16360349

8

Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial.

Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Chen MS, Crowe T, Loyd AB, Kapadia S, Nissen SE. Sipahi I, et al. Among authors: nicholls sj. Atherosclerosis. 2006 Nov;189(1):229-35. doi: 10.1016/j.atherosclerosis.2005.12.006. Epub 2006 Jan 20. Atherosclerosis. 2006. PMID: 16427643 Clinical Trial.

9

Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano.

Nicholls SJ, Tuzcu EM, Sipahi I, Schoenhagen P, Crowe T, Kapadia S, Nissen SE. Nicholls SJ, et al. J Am Coll Cardiol. 2006 Mar 7;47(5):992-7. doi: 10.1016/j.jacc.2005.11.040. Epub 2006 Feb 9. J Am Coll Cardiol. 2006. PMID: 16516083 Free article. Clinical Trial.

10

Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial.

Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Ozduran V, Kapadia S, Nissen SE. Sipahi I, et al. Among authors: nicholls sj. Eur Heart J. 2006 Jul;27(14):1664-70. doi: 10.1093/eurheartj/ehi796. Epub 2006 Mar 8. Eur Heart J. 2006. PMID: 16524891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

613 results

Search Page